Bridgepoint to buy Obagi Medical for up to $460m
Publicly traded global multi-brand beauty and wellness platform Waldencast is selling its Obagi Medical skincare and aesthetics business to the private equity firm Bridgepoint. For Bridgepoint, the acquisition bolsters its expanding track record across the dermatology, aesthetics, and professional skincare ecosystem. Obagi Medical, a pioneer in physician-dispensed skincare, expanded its addressable market through its 2025 acquisition of Novaestiq and the…